Suppr超能文献

蔗糖肾病再现:大剂量静脉注射免疫球蛋白治疗引起的急性肾衰竭。

Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.

作者信息

Zhang R, Szerlip H M

机构信息

Department of Medicine, Tulane University School of Medicine, New Orleans 70112, USA.

出版信息

South Med J. 2000 Sep;93(9):901-4.

Abstract

Sucrose nephropathy was first described more than 50 years ago. The disorder is characterized by acute renal failure caused by the uptake of sucrose by renal proximal tubule cells with subsequent cellular swelling and occlusion of the tubule lumen. Approximately 114 cases of renal failure have been associated with high-dose intravenous immune globulin (IVIG) therapy. Almost all cases were caused by preparations containing large amounts of sucrose. Clinicians should consider using IVIG preparations containing no sucrose in patients who are at high risk for renal failure. Risk factors include older age, baseline renal failure, and volume contraction.

摘要

蔗糖肾病在50多年前首次被描述。该病症的特征是急性肾衰竭,由肾近端小管细胞摄取蔗糖,随后细胞肿胀和小管腔阻塞引起。约114例肾衰竭病例与大剂量静脉注射免疫球蛋白(IVIG)治疗有关。几乎所有病例都是由含有大量蔗糖的制剂引起的。对于有肾衰竭高风险的患者,临床医生应考虑使用不含蔗糖的IVIG制剂。风险因素包括年龄较大、基线肾衰竭和容量收缩。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验